Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Endocr Relat Cancer. 2024 Jun 18;31(8). doi: 10.1530/ERC-24-0040. Print 2024 Aug 1.
The genetic alterations currently identified in papillary thyroid microcarcinomas (PTMCs) are insufficient for distinguishing tumors with aggressive features. We aimed to identify candidate markers associated with lateral lymph node metastasis (LLNM, N1sb disease) in patients with PTMC using transcriptomic analysis. RNA sequencing was performed on 26 matched tumor and normal thyroid tissue samples (N0, n = 14; N1b, n = 12), followed by functional enrichment analyses of differentially expressed genes (DEGs). EcoTyper was used to explore the distinct tumor microenvironment (TME). We identified 631 DEGs (213 upregulated and 418 downregulated) between N1b and N0 PTMCs. The most significantly upregulated genes in N1b were associated with tumorigenesis, adhesion, migration, and invasion. DEGs were mainly enriched in the pathways of idiopathic pulmonary fibrosis, TME, wound healing, and inhibition of matrix metalloproteases. We predicted the activation of these pathways in N1b PTMCs. N1b PTMCs had a unique TME with abundant fibroblasts and epithelial cells, associated with an increased risk of disease progression. Fibroblast marker genes, including POSTN, MMP11, TNFAIP6,and FN1, and epithelial cell marker genes, including NOX4, MFAP2, TGFVBI,and TNC, were selected. POSTN and FN1, fibroblast cell-specific genes, and NOX4 and TNC, epithelial cell-specific genes, were promising biomarkers for predicting LLNM development and recurrence in patients with PTMC. We delineated the cellular ecotypes within the TME of patients with N1b PTMC and revealed potential markers for predicting LLNM and the prognosis of PTMC. These findings provide valuable insights into the contributions of cancer-associated fibroblasts and epithelial cells to PTMC progression and metastasis.
乳头状甲状腺微小癌(PTMC)中目前鉴定的遗传改变不足以区分具有侵袭性特征的肿瘤。我们旨在通过转录组分析鉴定与 PTMC 患者侧颈部淋巴结转移(LLNM,N1sb 疾病)相关的候选标志物。对 26 对匹配的肿瘤和正常甲状腺组织样本(N0,n=14;N1b,n=12)进行 RNA 测序,然后对差异表达基因(DEGs)进行功能富集分析。EcoTyper 用于探索不同的肿瘤微环境(TME)。我们在 N1b 和 N0 PTMC 之间鉴定了 631 个 DEGs(213 个上调和 418 个下调)。N1b 中上调最显著的基因与肿瘤发生、黏附、迁移和侵袭有关。DEGs 主要富集在特发性肺纤维化、TME、伤口愈合和基质金属蛋白酶抑制途径中。我们预测了这些途径在 N1b PTMC 中的激活。N1b PTMC 具有独特的 TME,富含成纤维细胞和上皮细胞,与疾病进展风险增加有关。选择了成纤维细胞标记基因,包括 POSTN、MMP11、TNFAIP6 和 FN1,以及上皮细胞标记基因,包括 NOX4、MFAP2、TGFVBI 和 TNC。POSTN 和 FN1 是成纤维细胞特异性基因,NOX4 和 TNC 是上皮细胞特异性基因,是预测 PTMC 患者 LLNM 发展和复发的有前途的生物标志物。我们描绘了 N1b PTMC 患者 TME 中的细胞生态型,并揭示了预测 LLNM 和 PTMC 预后的潜在标志物。这些发现为癌症相关成纤维细胞和上皮细胞对 PTMC 进展和转移的贡献提供了有价值的见解。